Invisalign
Device Orthodontics
General payments
$89,447,375
Research payments
$378,769
Through program year 2025, $89,447,375 in general payments and $378,769 in research payments were reported against Invisalign (Orthodontics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
13 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $20,181,619 | 48,638 |
| 2024 | General | $16,648,689 | 55,330 |
| 2024 | Research | $83,068 | 42 |
| 2023 | General | $15,207,879 | 21,652 |
| 2023 | Research | $28,365 | 11 |
| 2022 | General | $16,717,505 | 42,372 |
| 2022 | Research | $36,991 | 33 |
| 2021 | General | $7,340,350 | 41,955 |
| 2021 | Research | $48,394 | 53 |
| 2020 | General | $7,749,176 | 35,111 |
| 2020 | Research | $53,642 | 974 |
| 2019 | General | $5,602,158 | 33,499 |
| 2019 | Research | $128,310 | 761 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 53 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
278,557 general · 1,874 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.